Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2003
05/08/2003US20030086904 Therapeutic regimen for treating cancer
05/08/2003US20030086903 Therapeutic regimen for treating cancer
05/08/2003US20030086901 Combination therapies using vitamin B12 and interferon for treatment of viral, proliferative and inflammatory diseases
05/08/2003US20030086900 Method of treatment using ligand-immunogen conjugates
05/08/2003CA2789114A1 Medical compositions for intravesical treatment of bladder cancer
05/08/2003CA2468761A1 Novel anticancer compounds
05/08/2003CA2466824A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003CA2466326A1 Tri-, tetra-, and penta-peptides having antiangiogenic activity
05/08/2003CA2466306A1 Di-, tri,- and tetra-peptides having antiangiogenic activity
05/08/2003CA2466152A1 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
05/08/2003CA2466148A1 Medical compositions for intravesical treatment of bladder cancer
05/08/2003CA2465714A1 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
05/08/2003CA2465682A1 Methods of treating leukemia
05/08/2003CA2465639A1 Tumor antigen
05/08/2003CA2465399A1 Alkane diol derivatives as therapeutic agents for the treatment of bone conditions
05/08/2003CA2465314A1 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
05/08/2003CA2465236A1 Substituted indoles, method for production and use thereof for the inhibition of pain
05/08/2003CA2465040A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003CA2464995A1 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
05/08/2003CA2464956A1 Detection of haematopoietic stem cells and progeny and uses thereof
05/08/2003CA2464944A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003CA2464924A1 Heteroaromatic carboxamide derivatives for the treatment of inflammation
05/08/2003CA2464656A1 Spray drying methods and compositions thereof
05/08/2003CA2464353A1 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003CA2464031A1 Purine analogs having hsp90-inhibiting activity
05/08/2003CA2463823A1 Aminobenzamide derivatives as glycogen synthase kinase 3.beta. inhibitors
05/08/2003CA2463822A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
05/08/2003CA2463821A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003CA2463580A1 Polymer conjugates of protein kinase c inhibitors
05/08/2003CA2463441A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003CA2462660A1 Nucleic acid-associated proteins
05/08/2003CA2462525A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003CA2451168A1 Methods for assessing and treating leukemia
05/08/2003CA2426785A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
05/07/2003EP1308511A1 Use of angiopoietin-like 1 and angiopoietin-like 2 nucleic acids and proteins for the treatment of blood-related disorders and defects in vasculature.
05/07/2003EP1308509A1 Novel physiologically active peptide and use thereof
05/07/2003EP1308462A1 Hepatitis b virus (hbv) antigenic polypeptide-heat shock protein complex and use thereof
05/07/2003EP1308447A1 Purine derivatives having antiproliferative properties and biological uses thereof
05/07/2003EP1308446A1 5-(alkylidene-cycloalkyl)- and 5-(alkylidene-heterocyclyl)-pyrazoles
05/07/2003EP1308445A1 5-heteroatom-substituted pyrazoles
05/07/2003EP1308444A1 Substituted 2-(2,6-Dioxo-3-Fluoropiperidine-3-YL)-Isoindolines and their use to reduce TNF-alpha Levels
05/07/2003EP1308440A1 Piperidine derivatives and drugs containing these derivatives as the active ingredient
05/07/2003EP1308439A1 Proline derivatives and use thereof as drugs
05/07/2003EP1308168A1 Novel remedies for cancer
05/07/2003EP1308161A1 5-N-heterocyclyl-1-(4-sulfonyl-phenyl)-1H-pyrazole derivatives with cyclooxygenase 2 (COX-2) inhibiting activity for the treatment of inflammatory diseases
05/07/2003EP1308158A1 Sulfonylaryl- and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/07/2003EP1307748A2 Assay method, peptides and reagent kits for testing mrp-specific inhibitors
05/07/2003EP1307746A1 Identification of viral agents in breast ducts and antiviral therapy therefore
05/07/2003EP1307594A1 Association of sim2 with cancer
05/07/2003EP1307579A2 Bio-intermediates for use in the chemical synthesis of polyketides
05/07/2003EP1307568A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof
05/07/2003EP1307567A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
05/07/2003EP1307566A2 Mitogen activated kinase
05/07/2003EP1307559A2 Slit-like protein obtained from a cdna library from hs-5 stromal cell line
05/07/2003EP1307557A2 Endothelial cell expression patterns
05/07/2003EP1307554A2 C3b/c4b complement receptor-like molecules and uses thereof
05/07/2003EP1307550A1 Human 7tm protein receptors and polynucleotides encoding the same
05/07/2003EP1307486A2 Somatostatin analogues
05/07/2003EP1307481A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression
05/07/2003EP1307480A2 Mutant trichosanthin
05/07/2003EP1307462A2 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
05/07/2003EP1307459A2 Indole compounds useful for the treatment of cancer
05/07/2003EP1307455A2 Inhibitors of alpha-l beta-2 mediated cell adhesion
05/07/2003EP1307454A1 Derivatives of variolin b
05/07/2003EP1307452A1 Use of polycyclic aromatic compounds for making medicines capable of inhibiting telomerase
05/07/2003EP1307450A2 2-(4-pyrdyl)amino-6-dialkoxyphenyl-pyrido(2.3-d)pyrimidin-7-ones
05/07/2003EP1307449A1 1,4-dihydropyridines as bradykinin antagonists
05/07/2003EP1307447A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
05/07/2003EP1307443A2 Novel substituted diaryl azepine derivatives as integrin ligands
05/07/2003EP1307439A2 Synthetic salicylihalamides, apicularens and derivatives thereof
05/07/2003EP1307425A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides
05/07/2003EP1307240A2 Radiolabelled metal transport protein as imaging agent
05/07/2003EP1307233A2 Therapeutic polyanhydride compounds for drug delivery
05/07/2003EP1307226A2 Vitronectin receptor antagonist pharmaceuticals
05/07/2003EP1307221A2 Modified sialic acid vaccines
05/07/2003EP1307220A1 Combined interferon alfa and liposomal-encapsulated all-trans retinoic acid, including preparation and use
05/07/2003EP1307219A2 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof
05/07/2003EP1307216A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
05/07/2003EP1307200A2 Substituted-triazolopyrimidines as anticancer agents
05/07/2003EP1307198A1 Protoberberine derivatives which inhibit activity of the mitogen-activated protein kinase
05/07/2003EP1307197A2 Compositions for the treatment of cancer comprising a topoisomerase inhibitor and thalidomide
05/07/2003EP1307188A1 Cannabinoid drugs
05/07/2003EP1307187A2 Use of 13-cis retinoic acid for the treatment of emphysema
05/07/2003EP1307186A1 Methods for decreasing cell proliferation based on (3r, 4r)-delta8-tetrahydrocannabinol-11-oic acids
05/07/2003EP1263447A4 Optically-active nanoparticles for use in therapeutic and diagnostic methods
05/07/2003EP1137433B1 Pharmaceutical compositions containing protein-disulfide isomerases
05/07/2003EP1112251B1 Azetidine derivatives, preparation and medicines containing them
05/07/2003EP0874621B1 [3'-DESOXY-3-OXO-MeBmT]1-[Val]2-CICLOSPORIN-CONTAINING EMULSION PHARMACEUTICAL COMPOSITIONS
05/07/2003EP0841929B1 Quinolones and their therapeutic use
05/07/2003EP0814807B1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
05/07/2003EP0669982B1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins
05/07/2003EP0627940B1 Use of immunoconjugates for the diagnosis and/or therapy of vascularized tumors
05/07/2003CN1416431A Nucleoside compounds and uses thereof
05/07/2003CN1416429A Pyrimidine derivatives having antitumor effect
05/07/2003CN1416428A Compounds having antitumor activity: process for their prepn.and pharmaceutical compsns. contg. them
05/07/2003CN1416423A 2,4,Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
05/07/2003CN1416416A Androgen receptor suppressors in treatment of hirsutism,acne and androgenetic alopecia
05/07/2003CN1416354A Vascular endothelial growth factor 2
05/07/2003CN1416349A Phy siologically active substance EEM-S originating in mushrooms, process for producing same and drugs
05/07/2003CN1416342A Condensation derivatives of thiocolchicine and baccatin as antitumor agents
1 ... 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 ... 2211